Volume 2, Issue 10, Pages (October 2015)

Slides:



Advertisements
Similar presentations
La néphropathie chronique en présence de diabète Canadian Journal of Diabetes Volume 37, Pages S504-S512 (October 2013) DOI: /j.jcjd
Advertisements

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Volume 18, Issue 2, Pages (March 2015)
Journal of Clinical Virology
Volume 59, Issue 6, Pages (December 2013)
Co-administration of BCG and Diphtheria-tetanus-pertussis (DTP) Vaccinations May Reduce Infant Mortality More Than the WHO-schedule of BCG First and Then.
The HPV Vaccine: Rates, Attitudes and Acceptibility
Volume 2, Issue 8, Pages (August 2015)
Oncolytic Viruses: Therapeutics With an Identity Crisis
Alcohol Consumption as a Risk Factor for Acute and Chronic Pancreatitis: A Systematic Review and a Series of Meta-analyses  Andriy V. Samokhvalov, Jürgen.
Copyright © 2015 by the American Osteopathic Association.
Volume 14, Issue 8, Pages (December 2011)
Is an Early Age at Illness Onset in Schizophrenia Associated With Increased Genetic Susceptibility? Analysis of Data From the Nationwide Danish Twin Register 
Volume 24, Pages (October 2017)
Cost-effectiveness of Pomalidomide, Carfilzomib, and Daratumumab for the Treatment of Patients with Heavily Pretreated Relapsed–refractory Multiple Myeloma.
Ann Intern Med. 2013;159(11): doi: / Figure Legend:
M. Yldau van der Ende, Minke H. T. Hartman, Yanick Hagemeijer, Laura M
The Lancet Public Health
Evolution of the incidence of hepatitis B virus infection and immunization rates in a large French cohort born between 1960 and 1994  C. Ramière, L. Roche,
Value in Health Regional Issues
Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus  T. Bärnighausen, D.E. Bloom, E.T. Cafiero,
S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler 
Herpes zoster in non-hospitalized children
A comparison of open and endovascular revascularization for chronic mesenteric ischemia in a clinical decision model  Wouter Hogendoorn, MD, M.G. Myriam.
Gauree Gupta, Ebbing Lautenbach, James D. Lewis 
When fasted is not empty: a retrospective cohort study of gastric content in fasted surgical patients†   P Van de Putte, L Vernieuwe, A Jerjir, L Verschueren,
Alexander M. Walker, MD, DrPH, Dimitri Bennett, MD, MPH  Heart Rhythm 
H-H. Lin, K-L. Hsu, W. W-C. Ko, Y-C. Yang, Y-W. Chang, M-C. Yu, K-T
Alexander M. Walker, MD, DrPH, Dimitri Bennett, MD, MPH  Heart Rhythm 
Cost-Effectiveness Analysis of Hepatitis B Immunization in Vietnam: Application of Cost- Effectiveness Affordability Curves in Health Care Decision Making 
Cost-Effectiveness of Helicopter Versus Ground Emergency Medical Services for Trauma Scene Transport in the United States  M. Kit Delgado, MD, MS, Kristan.
Volume 144, Issue 1, Pages e6 (January 2013)
M. Yldau van der Ende, Minke H. T. Hartman, Yanick Hagemeijer, Laura M
Covering the Cover Gastroenterology
Amnon Sonnenberg, MD, MSc, Brent Y. Lee, MD 
Coronary computed tomography versus exercise testing in patients with stable chest pain: comparative effectiveness and costs  Tessa S.S. Genders, Bart.
Allergen sensitization in a birth cohort at midchildhood: Focus on food component IgE and IgG4 responses  Jeffrey M. Wilson, MD, PhD, Lisa Workman, BA,
Screening individuals with intracranial aneurysms for abdominal aortic aneurysms is cost-effective based on estimated coprevalence  Benjamin Z. Ball,
Value in Health Regional Issues
Cost-Effectiveness Analysis of a Screening Program for Breast Cancer in Vietnam  Lan Hoang Nguyen, Wongsa Laohasiriwong, John Frederick Stewart, Pamela.
Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study  Mark Jit, PhD, Marc Brisson, PhD, Allison Portnoy,
Value in Health Regional Issues
Value in Health Regional Issues
Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis  Cynthia Chen, PhD, Francisco Cervero Liceras, MSc, Stefan.
Economic and health effect of full adherence to controller therapy in adults with uncontrolled asthma: A simulation study  Zafar Zafari, BSc, MSc, Larry.
G.S. Whiteley, T.O. Glasbey, P.P. Fahey  Infection, Disease & Health 
Figure 11-1.
Infant-feeding patterns and HIV-1 transmission
Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry  Hyuna Sung, PhD, Rebecca L Siegel, MPH, Philip S.
DNA transfer and cell type inference to assist activity level reporting: Post-activity background samples as a control in dragging scenario  Margreet.
Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study 
Cost-Effectiveness Analysis Expands its Reach Worldwide
Cost Effectiveness of Alternative Surveillance Strategies for Hepatocellular Carcinoma in Patients With Cirrhosis  Karin L. Andersson, Joshua A. Salomon,
Figure Overview.
Volume 4, Issue 5, Pages 2-3 (October 2006)
Figure Overview.
Incidence and severity of childhood pneumonia in the first year of life in a South African birth cohort: the Drakenstein Child Health Study  Dr David.
Clinical Microbiology and Infection
Varicella-Zoster Reactivation after Allogeneic Stem Cell Transplantation without Routine Prophylaxis—The Incidence Remains High  Ola Blennow, Gustav Fjaertoft,
ACRM 2012 Summer Archives Supplement: Request for Proposals
Effect of mass paediatric influenza vaccination on existing influenza vaccination programmes in England and Wales: a modelling and cost-effectiveness.
Is an increased drop-in rate appropriate with enhanced DNA profiling?
Table of contents The Journal for Nurse Practitioners
Table of contents The Journal for Nurse Practitioners
Volume 9, Issue 5, (October 2011)
James D. Stanger, Long Vo, John L. Yovich, Ghanim Almahbobi 
Volume 4, Issue 1, Pages 2-3 (February 2006)
Volume 163, Issue 2, (October 2015)
Cutaneous Leishmaniasis Due to Leishmania aethiopica
Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study  Gayatri Amirthalingam,
Presentation transcript:

Volume 2, Issue 10, Pages 1494-1499 (October 2015) Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster  Alies van Lier, Anna Lugnér, Wim Opstelten, Petra Jochemsen, Jacco Wallinga, François Schellevis, Elisabeth Sanders, Hester de Melker, Michiel van Boven  EBioMedicine  Volume 2, Issue 10, Pages 1494-1499 (October 2015) DOI: 10.1016/j.ebiom.2015.08.017 Copyright © 2015 Terms and Conditions

Fig. 1 VZV seroprevalence in 2006–2007 (blue dots) and herpes zoster incidence in the period 2002–2011 (orange dots) in the Netherlands. The sizes of the dots reflect sample sizes. Total numbers of sera and herpes zoster cases are 6251 and 7026, respectively. Thin grey lines indicate fits of transmission models with and without immune boosting. See the Supplement for details. EBioMedicine 2015 2, 1494-1499DOI: (10.1016/j.ebiom.2015.08.017) Copyright © 2015 Terms and Conditions

Fig. 2 Impact of varicella vaccination by birth cohort on the occurrence of varicella and herpes zoster. The vaccination programme started in 2020. See Table 1 for an overview of scenarios. EBioMedicine 2015 2, 1494-1499DOI: (10.1016/j.ebiom.2015.08.017) Copyright © 2015 Terms and Conditions

Fig. 3 Impact of varicella vaccination over time on the occurrence of varicella and herpes zoster. The vaccination programme started in 2020. See Table 1 for an overview of scenarios. EBioMedicine 2015 2, 1494-1499DOI: (10.1016/j.ebiom.2015.08.017) Copyright © 2015 Terms and Conditions

Fig. 4 Stylised overview of the cost-effectiveness of high-coverage (95%) varicella vaccination programme over time. Incremental cost-effectiveness ratio (ICER) threshold is set at €20,000 per QALY. This figure is based on data contained in Figures S10–S11. See the Supplement for details and sensitivity analyses. EBioMedicine 2015 2, 1494-1499DOI: (10.1016/j.ebiom.2015.08.017) Copyright © 2015 Terms and Conditions

EBioMedicine 2015 2, 1494-1499DOI: (10.1016/j.ebiom.2015.08.017) Copyright © 2015 Terms and Conditions

EBioMedicine 2015 2, 1494-1499DOI: (10.1016/j.ebiom.2015.08.017) Copyright © 2015 Terms and Conditions

EBioMedicine 2015 2, 1494-1499DOI: (10.1016/j.ebiom.2015.08.017) Copyright © 2015 Terms and Conditions

EBioMedicine 2015 2, 1494-1499DOI: (10.1016/j.ebiom.2015.08.017) Copyright © 2015 Terms and Conditions

EBioMedicine 2015 2, 1494-1499DOI: (10.1016/j.ebiom.2015.08.017) Copyright © 2015 Terms and Conditions

EBioMedicine 2015 2, 1494-1499DOI: (10.1016/j.ebiom.2015.08.017) Copyright © 2015 Terms and Conditions

EBioMedicine 2015 2, 1494-1499DOI: (10.1016/j.ebiom.2015.08.017) Copyright © 2015 Terms and Conditions

EBioMedicine 2015 2, 1494-1499DOI: (10.1016/j.ebiom.2015.08.017) Copyright © 2015 Terms and Conditions

EBioMedicine 2015 2, 1494-1499DOI: (10.1016/j.ebiom.2015.08.017) Copyright © 2015 Terms and Conditions

EBioMedicine 2015 2, 1494-1499DOI: (10.1016/j.ebiom.2015.08.017) Copyright © 2015 Terms and Conditions

EBioMedicine 2015 2, 1494-1499DOI: (10.1016/j.ebiom.2015.08.017) Copyright © 2015 Terms and Conditions

EBioMedicine 2015 2, 1494-1499DOI: (10.1016/j.ebiom.2015.08.017) Copyright © 2015 Terms and Conditions

EBioMedicine 2015 2, 1494-1499DOI: (10.1016/j.ebiom.2015.08.017) Copyright © 2015 Terms and Conditions

EBioMedicine 2015 2, 1494-1499DOI: (10.1016/j.ebiom.2015.08.017) Copyright © 2015 Terms and Conditions

EBioMedicine 2015 2, 1494-1499DOI: (10.1016/j.ebiom.2015.08.017) Copyright © 2015 Terms and Conditions

EBioMedicine 2015 2, 1494-1499DOI: (10.1016/j.ebiom.2015.08.017) Copyright © 2015 Terms and Conditions

EBioMedicine 2015 2, 1494-1499DOI: (10.1016/j.ebiom.2015.08.017) Copyright © 2015 Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.